147 related articles for article (PubMed ID: 37695458)
1. Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
Englum BR; Sahoo S; Mayorga-Carlin M; Hayssen H; Siddiqui T; Turner DJ; Sorkin JD; Lal BK
Ann Surg Oncol; 2023 Dec; 30(13):8509-8518. PubMed ID: 37695458
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
4. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
[TBL] [Abstract][Full Text] [Related]
5. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
6. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
[TBL] [Abstract][Full Text] [Related]
7. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
Tran C; Cipriano LE; Driman DK
CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic.
Kaufman HW; Chen Z; Niles JK; Radcliff J; Fesko Y
JCO Clin Cancer Inform; 2021 Sep; 5():1028-1033. PubMed ID: 34648367
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
11. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
[TBL] [Abstract][Full Text] [Related]
12. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
Lowry KP; Bissell MCS; Miglioretti DL; Kerlikowske K; Alsheik N; Macarol T; Bowles EJA; Buist DSM; Tosteson ANA; Henderson L; Herschorn SD; Wernli KJ; Weaver DL; Stout NK; Sprague BL
Radiology; 2022 May; 303(2):287-294. PubMed ID: 34665032
[TBL] [Abstract][Full Text] [Related]
13. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
[TBL] [Abstract][Full Text] [Related]
14. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
[TBL] [Abstract][Full Text] [Related]
15. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta.
Heer E; Ruan Y; Boyne DJ; Jarada TN; Heng D; Henning JW; Morris DM; O'Sullivan DE; Cheung WY; Brenner DR
CMAJ; 2023 Jun; 195(23):E804-E812. PubMed ID: 37308211
[TBL] [Abstract][Full Text] [Related]
16. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 on hospital screening, diagnosis and treatment activities among prostate and colorectal cancer patients in Canada.
Lee SH; Ojo AT; Halat M; Bleibdrey N; Zhang S; Chalmers R; Zimskind D
Int J Health Econ Manag; 2023 Sep; 23(3):345-360. PubMed ID: 37005943
[TBL] [Abstract][Full Text] [Related]
18. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
[TBL] [Abstract][Full Text] [Related]
19. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
[TBL] [Abstract][Full Text] [Related]
20. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]